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LETTERS TO THE EDITOR 
Effects of Physiologic and Pharmacologic 
Adrenergic Stimulation on Heart 
Rate Variability 
The report by Ahmed et al. (1) in a recent issue of the Journal 
examines the influence of exogenous beta-sympathomimetic agents, 
postural stress and exercise on time and frequency domain measures of 
heart rate variability, presumably as a model to explain the heart rate 
variability observed in disease states that are characterized by in- 
creased sympathetic drive. Several points regarding this report require 
reconsideration. 
The results reported concerning the effect of isoproterenol n 
heart rate variability differ markedly from those noted by Binkley et al. 
(2) in a similar group of subjects but with lower doses of isoproterenol. 
In that report, a marked increase in low frequency heart rate variability 
was observed, and there was little change in the high frequency 
variability. A recent editorial by Malik and Camm (3) points to an 
important mechanism that may account for these differences that was 
not discussed by Ahmed et al. As Malik and Camm note, extremes of 
stimulation of the sinus node such that it is effectively "saturated" and 
thus maximally stimulated o not permit the superimposition of
variability on the resultant extremes of heart rate. Indeed, isoproter- 
enol in the report by Ahmed et al. produced the greatest increase in 
heart rate of any of the maneuvers, and the above mechanism ost 
likely accounts for the observed decrease in both low and high 
frequency heart rate variability and the difference between these data 
and those of Binkley et al., in which a much lower stimulating dose of 
isoproterenol was used. Exercise, that produced the second highest 
increase in heart rate in the Ahmed et al. study, had a similar effect, 
most likely due to the same mechanism. Thus, as the report by Binkley 
et al., as well as others, has shown, low frequency heart rate variability 
can reflect beta-sympathomimetic stimulation but within recognized 
extremes of stimulation, as noted by Malik and Camm. It is not 
therefore so much the difference in exogenous versus endogenous 
neural stimulation that accounts for these effects, but the magnitude of 
stimulation. Conversely, the absence of change in heart rate variability 
with administration f beta-blockade indicates that these subjects had 
little rest sympathetic tone under the study conditions. This is corrob- 
orated by the lack of change in heart rate with administration of the 
beta-blocker. 
The supposition that administration f substances such as epineph- 
rine mimic the environment encountered in congestive heart failure 
and thus lend insight into the heart rate variability observed in this 
condition is erroneous. Although epinephrine may be increased to 
some extent in congestive heart failure, it is norepinephrine, rather 
than epinephrine, that has pathophysiologic a tivity in this condition. 
This increase in norepinephrine is in fact an epiphenomenon resulting 
from the "spillover" of this neurotransmitter, which follows from the 
greatly enhanced sympathetic drive of this patient group. Accordingly, 
it is not the influence of circulating norepinephrine that accounts for 
the observed changes in heart rate variability, but the direct effect of 
augmented sympathetic nerve trail]c, reflected by the increase in 
circulating norepinephrine, that produces these changes. Indeed, the 
intervention i the Ahmed et al. study that most closely simulates the 
sympathetic activation encountered in congestive heart failure was 
postural stress, which produced changes in low and high frequency 
variability, which would be expected under conditions of increased 
sympathetic drive and reduced parasympathetic tone noted in patients 
with congestive heart failure. 
To state that these data force a reconsideration f the conclusions 
stated in previous tudies is to ignore the extensive work preceding the 
report by Ahmed et al. that demonstrates the limitations as well as the 
strengths of this methodology and that has been well recognized and 
stated by careful investigators in this area of research, Binkley et al. 
(2), as well as numerous other investigators, have confirmed that 
parasympathetic blockade alters low as well as high frequency variabil- 
ity. This dual control of low frequency variability was offered as a 
possible xplanation for the absence of change in low frequency heart 
rate variability with chronic angiotensin-converting e zyme inhibition 
in patients with congestive heart failure (4). It was speculated that 
decreases in sympathetic drive with angiotensin-converting e zyme 
inhibition were offset by concomitant increases in parasympathetic 
tone, resulting in the absence of any net change in low frequency 
variability (4). Similarly, the "alternative xplanation" offered by 
Ahmed et al. for previously reported changes in heart rate variability 
in response to angiotensin-converting e zyme inhibition are not tena- 
ble and in fact highlight the advantages of analyzing heart rate 
variability in the frequency rather than the time domain. In the time 
domain, one cannot distinguish whether the changes in total heart rate 
variability are due to the reported inverse relation between sympa- 
thetic activation and total heart rate variability (5) or to a specific 
augmentation of parasympathetic tone. However, the report by Bin- 
kley et al. clearly showed that the increase in total heart rate variability 
is entirely due to an increase in the high frequency component, and 
there is nothing in the report by Ahmed et al. or in previous 
investigations to indicate that high frequency heart rate variability is 
governed by any mechanism other than parasympathetic control. 
Therefore, the observations reported by Ahmed et al. do not truly 
vary, from those that could be predicted on the basis of the work of 
several investigators whose efforts have been fundamental to the 
development of these methods (6). The data of Ahmed et al. provide 
intriguing observations regarding the influence of exogenous stimuli of 
differing pharmacologic properties on heart rate variability but do not 
provide a valid model of disease states for the reasons noted previ- 
ously. Accordingly, these data serve as an example of the challenging 
insights into the physiologic and pathophysiologic mechanisms that 
may be elucidated by this system of analysis rather than discouraging 
the use of what has been and will continue to be a valuable tool for 
clinical investigation. 
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Reply 
Binkley raises important issues regarding our study on the effects of 
physiologic and pharmacologic adrenergic stimulation on heart rate 
variability that merit further clarification. He correctly points out that 
our findings with isoproterenol differ from those previously reported 
by his group (1). His explanation for the discrepancy is probably 
correct because we repeated isoproterenol stimulation in normal 
subjects at a dose of 25 ng/kg body weight per rain and showed that 
there is indeed an increase in low frequency power at the lower dose 
of stimulation. As Binkley points out, these findings are consistent with 
the mechanism proposed by Malik and Carom (2), which states that 
there is a decrease in heart rate variability with intense stimulation. We 
believe that our data regarding both sympathetic stimulation (3) and 
parasympathetic stimulation (4) support this hypothesis. However, the 
implications of this hypothesis are quite dramatic and may be appli- 
cable to other data of Binkley et aL as well. If a heart rate variability 
variable is considered a measure of autonomic tone, then it should 
increase monotonically as autonomic tone increases. However, the 
possibility that intense stimulation may bc associated with a low heart 
rate variability value, as proposed by Malik and Carom, implies that 
both low and high levels of autonomic tone may be associated with a 
low heart rate variability. Binkley notes that in his study of congestive 
heart failure, there was a "greatly enhanced sympathetic drive." On the 
basis of the mechanism of Malik and Camm, how can we be sure that 
a low value for any variable of heart rate variability in this situation 
reflects anything but intense sympathetic stimulation? Furthermore, 
Binkley notes incorrectly that there are no data in our study to suggest 
that high frequency power is governed by any mechanism other than 
parasympathetic control. In fact, sympathetic stimulation was associ- 
ated with a decrease in high frequency power for some conditions. 
Other investigators (5) have also noted a decrease in the high 
frequency component with sympathetic stimulation. Thus, treatment 
with an angiotensin-converting enzyme inhibitor, which may diminish 
the sympathetic drive in these patients, may thereby result in an 
increase in heart rate variability, perhaps even the high frequency 
power. This alternative hypothesis certainly does not negate the 
possibility that there is also an increase in parasympathetic tone. 
Another important issue raised by Binkley is whether there is a 
difference in the heart rate variability response to pharmacologic 
beta-adrenergic stimulation versus endogenous neural stimulation. 
Clearly, in the current study (3) only upright ilt was associated with an 
increase in the low frequency power, suggesting that this maneuver 
results in different effects on heart rate variability from those observed 
with pharmacologic beta-adrenergic stimulation. We further tested 
this hypothesis by removing the confounding influence of parasympa- 
thetic tone (6). Upright tilt after atropine administration was associ- 
ated with a significant increase in the low frequency power, whereas 
isoproterenol (given at a dose [25 ng/kg body weight per min] that 
resulted in an increase in low frequency power in the absence of 
atropine) did not increase the low frequency power (6). It therefore 
appears that the heart rate variability response to sympathetic stimu- 
lation does depend on the type of stimulation. 
Finally, although in congestive heart failure the increase in sympa- 
thetic tone may be predominantly neurally mediated, there are a 
variety of physiologic states that are associated predominantly with an 
epinephrine response or a mixed epinephrine/norepinephrine re- 
sponse (7). Thus, it may be important to understand the effects of 
circulating catecholamines on heart rate variability. 
In summa~, our findings highlight he observation made by Malik 
and Camm (2) that "the idea that in all different circumstances, the 
heart rate variability components closely reflect the degree of auto- 
nomic tone has no solid basis." However, there is clearly important 
information that can be gleaned from heart rate variability analysis. It 
is the challenge for the future to develop a better physiologic model 
that will allow us to use these techniques tobetter evaluate changes in 
autonomic tone. 
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